Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study

Background: Transitioning patients between cholinesterase inhibitors was thought to require a washout period to avoid cholinergic toxicity; however, evidence suggests that abrupt discontinuation of donepezil may lead to cognitive decline. We evaluated the safety and tolerability of an immediate swit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sadowsky, Carl H., Farlow, Martin R., Atkinson, Leone, Steadman, Jennifer, Koumaras, Barbara, Chen, Michael, Mirski, Dario
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Physicians Postgraduate Press, Inc. 2005
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1079694/
https://ncbi.nlm.nih.gov/pubmed/15841194
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak